SAM # Amendment

FDA Solicitation Amendment: AI-Accelerated Computational Modeling and Simulation for Cardiovascular Devices

This opportunity is an amendment to an FDA solicitation focused on advancing the reliability of AI-accelerated computational modeling and simulation for cardiovascular devices. - Government Buyer: - Department of Health and Human Services (HHS) - Food and Drug Administration (FDA) - Office of Acquisition and Grant Services - No specific OEMs or commercial vendors are named in the solicitation or amendment. - Products/Services Requested: - Services supporting quantitative decision reliability in AI-driven computational modeling and simulation for cardiovascular devices - No hardware, software products, or part numbers are specified - Emphasis on expertise in AI, computational modeling, and medical device simulation - Unique/Notable Requirements: - Focus on quantitative decision reliability for regulatory or scientific decision-making - Application of AI-accelerated methods to medical device simulation - Amendment addresses questions from potential offerors regarding the original solicitation

Description

This is an amendment to RFQ133983 to provide response to questions that were received.

Responses are dye by 10AM EST on or before 08/07/2026

View original listing